Monoclonal antibodies as effective therapeutic agents for solid tumors.
about
Treatment of solid tumors with immunotoxins.Molecular pathology of lung cancer: key to personalized medicine.Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapyMUC1 cytoplasmic tail: a potential therapeutic target for ovarian carcinomaEffect of 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid in combination with carboplatin on gastric carcinoma growth in vivoEffective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormoneSystems biology modeling reveals a possible mechanism of the tumor cell death upon oncogene inactivation in EGFR addicted cancers.Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapiesAnti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells.Immunotherapy and immunoprevention of cancer: where do we stand?Cripto as a target for cancer immunotherapy.The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it?Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.Screening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker.Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells.Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells.Anti-tumor effect of the anti-KL-6/MUC1 monoclonal antibody through exposure of surface molecules by MUC1 capping.
P2860
Q24813585-3E3457A0-5402-4296-8315-28E0D28B3E5EQ27691299-BAD6A889-F281-452F-A221-69A48959A0BBQ28242840-483ADFA2-6B19-4C13-8E4E-AF6573786456Q28259350-51D41D55-8345-4723-B547-99A41D7CB162Q33787907-A6AE3B02-D651-424F-BF6C-F58A5D1565FBQ33906715-5B3190DB-BC77-47BD-839C-5B3C06BB166EQ34110540-A6255ABA-ED91-402B-829B-7612FE94A5BAQ35741295-114CE759-F03E-46BD-937A-4813C82A2AD8Q36060249-6C53F822-3E03-43C7-95CB-BCBFF407256BQ36150524-5AF14929-91A6-4AE4-B303-9AA99DDF45D4Q36150872-62A5F1E6-4AAA-4298-B64C-C0C85DB4CC9BQ36268324-AF8F493E-E37B-4221-AAEA-C6974CEAAFD5Q36494268-DC99607E-6FEE-44D1-9C1F-40AAE2D48249Q37703226-645D1972-4154-43EB-A1FB-3CF15E99459BQ38704948-4409B361-BFC9-4498-B24F-2BF238462E5DQ39870310-C709372F-7D44-4934-AD8A-5DB33B39AEB8Q40252778-2F6B8F26-C820-47EA-B92B-8954D88ABAD3Q40289314-B0386EFE-C5D4-4C79-89F7-AF70E2C375E0
P2860
Monoclonal antibodies as effective therapeutic agents for solid tumors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Monoclonal antibodies as effective therapeutic agents for solid tumors.
@ast
Monoclonal antibodies as effective therapeutic agents for solid tumors.
@en
type
label
Monoclonal antibodies as effective therapeutic agents for solid tumors.
@ast
Monoclonal antibodies as effective therapeutic agents for solid tumors.
@en
prefLabel
Monoclonal antibodies as effective therapeutic agents for solid tumors.
@ast
Monoclonal antibodies as effective therapeutic agents for solid tumors.
@en
P2093
P2860
P1433
P1476
Monoclonal antibodies as effective therapeutic agents for solid tumors.
@en
P2093
Kohzoh Imai
Shigeru Sasaki
Tadao Ishida
Yuji Hinoda
P2860
P304
P356
10.1111/J.1349-7006.2004.TB03319.X
P577
2004-08-01T00:00:00Z